₹24.15
(Market cap
₹41,836 Cr
Recently Viewed
Clear AllMarket cap
₹41,836 Cr
Revenue (TTM)
₹1,845 Cr
P/E Ratio
92.7
P/B Ratio
14.7
Div. Yield
0 %
Value Research Rating
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹451 Cr
ROE
21 %
ROCE
28.5 %
Industry P/E
--
EV/EBITDA
54.7
Debt to Equity
0
Book Value
₹42.5
EPS
₹8.1
Face value
2
Shares outstanding
561,713,851
CFO
₹759.16 Cr
EBITDA
₹3,250.30 Cr
Net Profit
₹2,202.40 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Anthem Biosciences
| 14.3 | 12.8 | 18.2 | -- | -- | -- | -- |
|
BSE Healthcare
| -1.9 | -1.8 | -2.4 | 7.7 | 24.3 | 13.4 | 10.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Anthem Biosciences
|
744.4 | 41,836.5 | 1,844.6 | 451.3 | -- | 21 | 92.7 | 14.7 |
| 7,511.5 | 1,08,049.9 | 24,215.2 | 1,820.5 | 11.0 | 21 | 60 | 11.3 | |
| 681.8 | 35,294.4 | 4,461.2 | 397.5 | 13.4 | 9.1 | 107.9 | 7.7 | |
| 847.9 | 63,978.9 | 8,770.4 | 966.3 | 17.8 | 11 | 66.7 | 6.6 | |
| 79.0 | 357.6 | 0.0 | -0.2 | -- | -2.8 | -- | 8.8 | |
| 1,066.2 | 28,631.6 | 4,182.4 | 513.8 | 16.6 | 15.6 | 55.7 | 7.5 | |
| 68.0 | 135.5 | 50.3 | -2.1 | -3.3 | -6.3 | -- | 2.1 | |
| 953.4 | 92,842.6 | 8,140.3 | 1,419.2 | 21.2 | 15 | 65.4 | 9.0 | |
| 1,754.9 | 35,856.1 | 6,777.7 | 782.9 | 16.1 | 21.5 | 46 | 8.6 | |
| 463.2 | 2,069.5 | 392.5 | 74.7 | 24.2 | 19.1 | 27.7 | 4.8 |
Anthem Biosciences IPO analysis
5 min read•By Abhinav Goel
--
Incorporated
2006
Chairman
Ajay Bhardwaj
Managing Director
Ajay Bhardwaj
Headquarters
Bengaluru, Karnataka
Website
Looking for more details about Anthem Biosciences Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Anthem Biosciences Ltd is ₹744.40 (NSE) and ₹744.80 (BSE) as of 10-Apr-2026 IST. Anthem Biosciences Ltd has given a return of --% in the last 1 years.
The P/E ratio of Anthem Biosciences Ltd is 92.71 times as on 10-Apr-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Anthem Biosciences Ltd are Rs 873.50 and Rs 579.15 as of 10-Apr-2026.
Anthem Biosciences Ltd has a market capitalisation of ₹ 41,836 Cr as on 10-Apr-2026. As per SEBI classification, it is a Mid Cap company.
Before investing in Anthem Biosciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.